Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

Patrick Carew at Dave Decker Photography in Ybor City, Florida on Jan. 12, 2026. Tampa art insiders know Patrick Carew as the curator of Reverb, a small ...

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

African HIV vaccine trial lost funding last year when the Trump administration shut down much of foreign aid. The setback was devastating but the researchers refused to give up.

Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells in lab studies. Here’s what the research means and what comes next.

Aotearoa has lost a powerful voice for health equity and human dignity with the passing of Marama Martin, a dedicated HIV ...

The Experimental Learning Symposium was held in November as an opportunity for over 50 undergraduates in health science ...

An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found.

Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...